Population Pharmacokinetics (PopPK) of Quizartinib and Its Active Metabolite AC886 in Patients (Pts) With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) ACoP13 (Nov 2022), Poster M-027 Vaddady P, Smania G, Glatard A, Nakayama S, Inoue H, Kurumaddali A, Abutarif M, Sheng M. ConferenceMIDDOncologyPharmacometricsRegulatory interactions Pharmetheus Affiliates Principal Director, MIDD Consultant Giovanni Smania See bio Senior Director, MIDD Consultant Anaïs Glatard See bio
